Industry

The Center’s unique R&D structure is explicitly aimed at developing leading-edge neural interface technologies into validated devices that can be used by researchers. CNCT’s strong interdisciplinary approach combines engineering and science to ultimately connect human-derived technology with biological structures and processes.

For companies with an interest in neurodevices and neural interface technologies, CNCT’s R&D activities have relevance to what may ultimately be their future bottom-line success. The work that takes place within the Center and among its collaborators provides a snapshot of what lays over the horizon in key areas of neural interfacing and neuroprosthetics. Such viewpoints help predict the trends that can fuel long-term strategic goals for industry participants.

In practical terms, the outcomes of CNCT research studies will provide advanced and detailed information regarding device performance, biocompatibility issues, and usage issues. This information and expertise will be relevant not only to CNCT devices, but to other implantable neurodevices as they move along the technology pipeline.

As a vehicle for advanced R&D, CNCT focuses primarily on developing technologies that can be readily transformed into commercial devices and applications. To meet this overriding goal, the Center forges strong bonds with industry. The Center’s operations and organizational structure are designed with technology transfer in mind. That is, the Center supports a vision where its work will enter the marketplace and be within the reach of those who will directly benefit from it.